[ad_1] Catalyst Pharmaceuticals (CPRX): The corporate ownership of the company is 49.90% while the insider property is 6.77%. The company managed to keep the return on invested capital (ROA) at -32.50% in the last twelve months. Return on equity (ROE) recorded at -34.10%. Catalyst Pharmaceuticals (CPRX) revealed a 3.85% move …
Read More »Catalyst Pharmaceuticals (CPRX) – Bitcoin and Stock Journal
